Analyst Research Report Snapshot

Title:

EVOLVA - PREPARED FOR THE STEVIA JV

Price:

$10.00

Provider:

Edison Investment Research

Date:

10 Mar 2014

Pages:

3

Type:

AcrobatPDF

Companies referenced:

EVE.S

Available for Immediate Download
Summary:

Evolva has indicated its intention to co-commercialise its stevia programme in a joint venture (JV) with Cargill by raising CHF37m. The final decision regarding the potential JV to market the high-intensity natural sweeteners is expected by early 2015. The first stevia products remain on track to be launched in 2015 or 2016, which should be Evolva's third product on the market. The launch of Evolva's vanillin by International Flavors & Fragrances (IFF) is imminent and Evolva plans to re-launch resveratrol in H214. We value Evolva at CHF1.73/share.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.